| Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins ES Kheder, DS Hong Clinical Cancer Research 24 (23), 5807-5814, 2018 | 159 | 2018 |
| Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center JGM Manzano, M Muthu, E Kheder, A Mohammed, J Halm, K Dickson, ... Supportive Care in Cancer 30 (9), 7783-7788, 2022 | 4 | 2022 |
| Characteristics of cancer patients with COVID-19 in a cancer hospital DN Lipe, A Elsayem, MT Cruz-Carreras, J Thomas, A Feliciano, J Ren, ... Annals of Palliative Medicine 10 (2), 1763771-1761771, 2021 | 4 | 2021 |
| The impact of statin therapy on survival for inhospital cardiac arrest R Khoury Abdulla, E Kheder, R Yeow, S Ginoya Meka, O Yaldo, ... Journal of Investigative Medicine 65 (7), 1-3, 2017 | 2 | 2017 |
| Strategic improvement of oral antineoplastic investigational agents compliance A Alshawa, J Gong, V Marcott, R Khan, V Boving, L Brown, J Beno, ... Global Journal on Quality and Safety in Healthcare 2 (1), 5-10, 2019 | 1 | 2019 |
| Inpatient outcomes of patients with new solid tumors admitted to a comprehensive cancer center. SV Nguyen, BA Stephen, SL Curry, J Halm, E Kheder Journal of Clinical Oncology 42 (16_suppl), e23056-e23056, 2024 | | 2024 |
| Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service JGM Manzano, H Sahar, J Aldrich, M Lu, M Shoukier, CB Peterson, ... Supportive Care in Cancer 32 (3), 160, 2024 | | 2024 |
| Understanding Potentially Preventable 7-day Readmission Rates in Hospital Medicine Patients at a Comprehensive Cancer Center CK Leung, NC Walton, E Kheder, A Zalpour, J Wang, D Zavgorodnyaya, ... American Journal of Medical Quality 39 (1), 14-20, 2024 | | 2024 |
| Association of presenting symptoms with COVID-19 disease severity and outcomes among hospitalized patients with cancer and COVID-19. N Ali, E Kheder, K Dickson, D Rubio, K Koom-Dadzie, P Edelkamp, ... Journal of Clinical Oncology 41 (16_suppl), e13581-e13581, 2023 | | 2023 |
| Improving Medication Reconciliation within 24 Hours of Admission to a Comprehensive Cancer Center L Saji, C Patel, E Kheder, R Iyer, L Michaud, L Harris, M George, ... The University of Texas MD Anderson Cancer Center, 2023 | | 2023 |
| Improving admission medication reconciliation at a tertiary cancer center. E Kheder, L Saji, A Zalpour, S Swanson, S Mandayam Journal of Clinical Oncology 39 (15_suppl), e18686-e18686, 2021 | | 2021 |
| Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes. HN Sahar, J Aldrich, CB Peterson, N Brito-Dellan, M Lu, M Shoukier, ... Journal of Clinical Oncology 39 (15_suppl), e21054-e21054, 2021 | | 2021 |
| 148: First-Surge COVID-19 Experience at a Comprehensive Cancer Center DR Reddy, R Wegner, J Crommett, M Muthu, E Kheder, JG Manzano, ... Critical Care Medicine 49 (1), 59, 2021 | | 2021 |
| Off-label use of everolimus and associated factors in non-elderly cancer patients with private insurance in the United States. Y Xing, Y Guo, JCN Chang, TA Patel, E Kheder, F Meric-Bernstam, ... Journal of Clinical Oncology 36 (15_suppl), e18718-e18718, 2018 | | 2018 |
| Non-V600 BRAF mutations in advanced malignancies: Prevalence and survival impact. E Kheder, Y Xing, KR Hess, F Janku, KR Shaw, L Huang, K Patel, ... Journal of Clinical Oncology 36 (15_suppl), 12100-12100, 2018 | | 2018 |
| TP53 mutations and programmed cell death ligand-1 expression in solid tumors: Associations with clinical factors and outcomes. E Kheder, KR Hess, Y Xing, MA Cortez, V Subbiah, F Janku, S Fu, ... Journal of Clinical Oncology 36 (15_suppl), 12052-12052, 2018 | | 2018 |
| Detection of circulating antibodies against KRAS in patients with advanced cancers E Kheder, HJ Huang, A Wu, DS Hong, SA Piha-Paul, DD Karp, S Fu, ... Cancer Research 77 (13_Supplement), 642-642, 2017 | | 2017 |
